ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 040,48
0,60%
Dow Jones
38 686,32
1,51%
DAX
18 676,25
1,05%
Brent Oil
81,28
0,59%
Bitcoin
69 128,22
2,04%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sierra Oncology Inc (SRRA)

  7. Sierra Oncology Inc (SRRA) Actualités

SRRA

Sierra Oncology (SRRA)

Sierra Oncology Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SRRA
DateHeureSourceTitreSymboleSociété
14/02/202321h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRRASierra Oncology Inc
18/07/202222h05GlobeNewswire Inc.Codexis Announces CEO Transition Effective August 9, 2022NASDAQ:SRRASierra Oncology Inc
11/07/202222h31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SRRASierra Oncology Inc
11/07/202222h02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:SRRASierra Oncology Inc
01/07/202223h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRRASierra Oncology Inc
01/07/202222h19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRRASierra Oncology Inc
01/07/202222h17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SRRASierra Oncology Inc
01/07/202222h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRRASierra Oncology Inc
01/07/202215h38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SRRASierra Oncology Inc
17/06/202213h00Business WireSierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug AdministrationNASDAQ:SRRASierra Oncology Inc
26/05/202223h00Business WireMomelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual MeetingNASDAQ:SRRASierra Oncology Inc
16/05/202222h16Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SRRASierra Oncology Inc
12/05/202216h00Business WireSierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual MeetingNASDAQ:SRRASierra Oncology Inc
06/05/202213h00Business WireSierra Oncology Reports First Quarter 2022 ResultsNASDAQ:SRRASierra Oncology Inc
05/05/202222h05Business WireSierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SRRASierra Oncology Inc
02/05/202222h57Business WireSIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRANASDAQ:SRRASierra Oncology Inc
22/04/202220h33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SRRASierra Oncology Inc
14/04/202213h26TipRanksWhy Did Sierra Oncology Skyrocket on Wednesday?NASDAQ:SRRASierra Oncology Inc
13/04/202223h17Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:SRRASierra Oncology Inc
13/04/202222h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SRRASierra Oncology Inc
13/04/202209h24Dow Jones NewsGlaxoSmithKline to Acquire Sierra Oncology for $1.9 Billion -- UpdateNASDAQ:SRRASierra Oncology Inc
13/04/202208h57Dow Jones NewsGlaxoSmithKline to Acquire Sierra Oncology for $1.9 BillionNASDAQ:SRRASierra Oncology Inc
13/04/202208h05Business WireGSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bnNASDAQ:SRRASierra Oncology Inc
14/03/202216h05TipRanksAnalysts Offer Insights on Healthcare Companies: Sierra Oncology (SRRA) and DarioHealth (DRIO)NASDAQ:SRRASierra Oncology Inc
11/03/202213h00Business WireSierra Oncology to Participate in the Oppenheimer 32nd Annual Healthcare ConferenceNASDAQ:SRRASierra Oncology Inc
10/03/202217h05TipRanksAnalysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV) and Sierra Oncology (SRRA)NASDAQ:SRRASierra Oncology Inc
10/03/202213h46Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SRRASierra Oncology Inc
10/03/202213h08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SRRASierra Oncology Inc
10/03/202213h00Business WireSierra Oncology Reports 2021 Year End ResultsNASDAQ:SRRASierra Oncology Inc
03/02/202222h05Business WireSierra Oncology Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:SRRASierra Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:SRRA

Dernières Valeurs Consultées

NASDAQ
SYTAW
Siyata Mobile
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés